project id: TCGA-READ; case submitter id: TCGA-AG-3600; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.0; rna integrity number: 9.2; spectrophotometer method: UV Spec; age at index: 62; days to birth: -22767; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1945; age at diagnosis: 22767; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 184.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.4; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-AG-3600-01A-01; percent necrosis: 0.0; percent normal cells: 10.0; percent stromal cells: 5.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;